Skip to main content
Erschienen in: Pathology & Oncology Research 2/2020

09.05.2019 | Original Article

Clinicopathologic Diagnostic and Prognostic Factors of Spindle Cell Carcinoma of Upper Airway

verfasst von: Amanda Bueno de Araújo, Thiago Luís Infanger Serrano, Maria Cláudia Mota Pedroso, Fernanda Viviane Mariano, Albina Altemani, Flavio Mignone Gripp, Agrício Nubiato Crespo, Carlos Takahiro Chone

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Spindle cell carcinoma (SpCC) is a rare tumor, which occurs in upper respiratory tract, mainly in larynx. This study aimed to review the clinical and pathological characteristics for diagnosis and prognosis. Retrospective cohort study. All patients with SpCC in upper respiratory tract treated for curative intent was included. All patients were reviewed in search of epithelial component and immunohistochemistry when not found. It was evaluated rate of recurrence and disease-free survival with univariate and multivariate analysis with Kaplan Meier and Cox Regression model adjusted to propensity score indexes (PSI) according to age, gender, site of tumor, stage, surgical treatment, status of margins of surgical resection, lymphatic invasion. There were 16 cases of SpCC.31% were diagnosed with light microscopy and others with immunohistochemistry for epithelial marker. Disease-free survival was higher in early stage disease in univariate and multivariate analysis, as the main prognostic factor. Surgical treatment increases in 2.54 the rate of survival. The SpCC is a rare tumor considered a highly malignant variant of squamous cell carcinoma. It has male predominance and tobacco use as risk factors. Its treatment should follow the same recommendations for squamous cell carcinoma, with surgery as the maintain treatment. Immunohistochemistry is an adjuvant important tool for diagnosis of SpCC.
Literatur
1.
Zurück zum Zitat Virchow V. Die Krankhaften Geschwfilste, vol 2. Berlin, Germany: A. Hirschwald; 1864-1865:181-182. Virchow V. Die Krankhaften Geschwfilste, vol 2. Berlin, Germany: A. Hirschwald; 1864-1865:181-182.
2.
Zurück zum Zitat Gupta R, Singh S, Hedau S, Nigam S, Das BC, Sigh I, Mandal AK (2007) Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis. J Clin Pathol 60:472–475CrossRef Gupta R, Singh S, Hedau S, Nigam S, Das BC, Sigh I, Mandal AK (2007) Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis. J Clin Pathol 60:472–475CrossRef
3.
Zurück zum Zitat Figi FA (1933) Sarcoma of the larynx. Arch Otolaryngol Head Neck Surg 18:21–33CrossRef Figi FA (1933) Sarcoma of the larynx. Arch Otolaryngol Head Neck Surg 18:21–33CrossRef
4.
Zurück zum Zitat Gerry D, Fritsch VA, Lentsch EJ (2014) Spindle cell carcinoma of upper aerodigestive tract: an analysis of 341 cases with comparison to conventional squamous cell carcinoma. Ann Otol Rhinol Laryngol 123(8):576–583CrossRef Gerry D, Fritsch VA, Lentsch EJ (2014) Spindle cell carcinoma of upper aerodigestive tract: an analysis of 341 cases with comparison to conventional squamous cell carcinoma. Ann Otol Rhinol Laryngol 123(8):576–583CrossRef
5.
Zurück zum Zitat Olsen K, Lewis JE, Suman VJ (1997) Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngol Head Neck Surg 116(1):47–52CrossRef Olsen K, Lewis JE, Suman VJ (1997) Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngol Head Neck Surg 116(1):47–52CrossRef
7.
Zurück zum Zitat Choi HR, Sturgis EM, Rosenthal DI, Luna MA, Batsakis JG, El-Naggar AK (2003) Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Am J Surg Pathol 27(9):1216–1220CrossRef Choi HR, Sturgis EM, Rosenthal DI, Luna MA, Batsakis JG, El-Naggar AK (2003) Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Am J Surg Pathol 27(9):1216–1220CrossRef
8.
Zurück zum Zitat Choi HR, Roberts DB, Johnigan RH, Sturgis EM, Rosenthal DI, Weber RS, Luna MA, Batsakis JG, El-Naggar AK (2004) Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol 28(10):1299–1310CrossRef Choi HR, Roberts DB, Johnigan RH, Sturgis EM, Rosenthal DI, Weber RS, Luna MA, Batsakis JG, El-Naggar AK (2004) Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol 28(10):1299–1310CrossRef
10.
Zurück zum Zitat Lewis JS, Ritter JH, El-Mofty S (2005 Nov) Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1. Mod Pathol 18(11):1471–1481CrossRef Lewis JS, Ritter JH, El-Mofty S (2005 Nov) Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1. Mod Pathol 18(11):1471–1481CrossRef
13.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) Head and neck. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) Cancer staging handbook from the AJCC Cancer staging manual, 7th edn. Springer, New York, pp 21–100 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) Head and neck. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) Cancer staging handbook from the AJCC Cancer staging manual, 7th edn. Springer, New York, pp 21–100
15.
Zurück zum Zitat Virchow V. Die Krankhaften Geschwfilste, vol 2. Berlin, Germany: A. Hirschwald; 1864-1865:181-182. Virchow V. Die Krankhaften Geschwfilste, vol 2. Berlin, Germany: A. Hirschwald; 1864-1865:181-182.
Metadaten
Titel
Clinicopathologic Diagnostic and Prognostic Factors of Spindle Cell Carcinoma of Upper Airway
verfasst von
Amanda Bueno de Araújo
Thiago Luís Infanger Serrano
Maria Cláudia Mota Pedroso
Fernanda Viviane Mariano
Albina Altemani
Flavio Mignone Gripp
Agrício Nubiato Crespo
Carlos Takahiro Chone
Publikationsdatum
09.05.2019
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2020
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-019-00654-9

Weitere Artikel der Ausgabe 2/2020

Pathology & Oncology Research 2/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.